Biosev S.A. | Income Statement
Fiscal year is April-March. All values BRL Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
4,268
4,513
6,163
7,025
7,104
6,232
Cost of Goods Sold (COGS) incl. D&A
3,276
3,793
5,484
6,668
6,471
5,642
Gross Income
991
720
679
357
632
590
SG&A Expense
583
510
551
571
591
442
Unusual Expense
432
273
83
223
606
69
Non Operating Income/Expense
622
630
595
243
242
1,011
Interest Expense
395
498
662
708
854
456
Pretax Income
1,101
658
887
381
1,686
1,374
Income Tax
364
170
3
211
421
186
Equity in Affiliates
2
11
6
8
5
11
Consolidated Net Income
1,467
499
885
600
1,270
1,199
Net Income
1,468
502
890
600
1,270
1,199
Net Income After Extraordinaries
1,468
502
890
600
1,270
1,199
Net Income Available to Common
1,468
502
890
600
1,270
1,199
EPS (Basic)
7.18
2.43
4.22
2.82
5.57
3.33
Basic Shares Outstanding
204
207
211
213
228
360
EPS (Diluted)
7.18
2.43
4.22
2.82
5.57
3.33
Diluted Shares Outstanding
204
207
211
213
228
360
EBITDA
929
1,183
1,386
1,334
1,470
1,471
Other Operating Expense
129
71
61
9
71
132
Non-Operating Interest Income
69
57
97
65
45
8
Minority Interest Expense
1
3
6
-
-
-
About Biosev
View Profile
